Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Bonfrer, J. M. G"'
Autor:
Gast, M. C. W.1 apmcg@slz.nl, Bonfrer, J. M. G.2, Van Dulken, E. J.3, De Kock, L.3, Rutgers, E. J. Th.4, Schellens, J. H. M.5, Beijnen, J. H.1,6
Publikováno v:
Cancer Biomarkers. 2006, Vol. 2 Issue 6, p235-248. 14p. 3 Diagrams, 5 Charts.
Autor:
Kappers, I., Vollebergh, M. A., Tinteren, H., Korse, C. M., Nieuwenhuis, L. L., Bonfrer, J. M. G., Klomp, H. M., Nico van Zandwijk, Den Heuvel, M. M.
Publikováno v:
ecancermedicalscience
ResearcherID
ResearcherID
Background: In patients with non-small cell lung cancer (NSCLC), a higher response rate can be achieved with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) when selection for therapy is guided by mutation analysis or gene amp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e1c93c1716d866f9e93636fe3035220d
http://europepmc.org/articles/PMC3234018
http://europepmc.org/articles/PMC3234018
Autor:
Smit, L. H. M., Nieweg, O. E., Mooi, W. J., Bonfrer, J. M. G., Haanen, J. B. A. G., Kroon, B. B. R., de Gast, G. C.
Publikováno v:
Anticancer research, 28(4C), 2297-2302. International Institute of Anticancer Research
BACKGROUND: The biochemical marker serum S-100B has been proven to reflect the stage of melanoma and to be useful for disease monitoring and prediction of survival, mainly in stage IV disease. For stage III melanoma, limited data are available and it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::1774a0509ccdba27ae77c761db567703
https://pure.amc.nl/en/publications/value-of-serum-s100b-for-prediction-of-distant-relapse-and-survival-in-stage-iii-bc-melanoma(a3e2b4ba-90bb-48aa-83c1-e5bac897d440).html
https://pure.amc.nl/en/publications/value-of-serum-s100b-for-prediction-of-distant-relapse-and-survival-in-stage-iii-bc-melanoma(a3e2b4ba-90bb-48aa-83c1-e5bac897d440).html
Publikováno v:
van Ruth, S, Hart, A A M, Bonfrer, J M G, Verwaal, V J & Zoetmulder, F A N 2002, ' Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy ', Annals of Surgical Oncology, vol. 9, no. 10, pp. 961-7 . https://doi.org/10.1245/ASO.2002.04.020, https://doi.org/10.1007/bf02574513
Background: Tumor markers are useful for diagnosis and follow-up. We studied the prognostic value of baseline and serial carcinoembryonic antigen (CEA) and carbohydrate antigen 19.9 (CA19.9) measurements in patients with pseudomyxoma peritonei treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::c19297c67f01a75d9a403b8c1c6939e8
https://portal.findresearcher.sdu.dk/da/publications/5cb72823-dda1-46cf-94ea-251d22607857
https://portal.findresearcher.sdu.dk/da/publications/5cb72823-dda1-46cf-94ea-251d22607857
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
British Journal of Cancer; 6/1/2004, Vol. 90 Issue 11, p2073-2079, 7p
Autor:
Van Doornum, G J J, Korse, C M, Buning-Kager, J C G M, Bonfrer, J M G, Horenblas, S, Taal, B G, Dillner, J
Publikováno v:
British Journal of Cancer; 4/7/2003, Vol. 88 Issue 7, p1095-1100, 6p
Autor:
Klaase, J. M., Swaanenburg, J. C. J. M., Schouwink, H., Sosef, M. N., Bonfrer, J. M. G., Zoetmulder, F. A. N., Rutgers, E. J. Th., Baas, P.
Publikováno v:
Photochemistry & Photobiology; Mar2000, Vol. 71 Issue 3, p351-354, 4p
Autor:
Hilkens, J., Bonfrer, J. M. G., Kroezen, V., Van Eykeren, M., Nooyen, W., De Jong-Bakker, M., Bruning, P. F.
Publikováno v:
International Journal of Cancer; Apr1987, Vol. 39 Issue 4, p431-435, 5p